For research use only
| Cat No. | ABC-SC2090 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | PBMC |
| Disease | Amyotrophic Lateral Sclerosis |
| Storage | Liquid Nitrogen |
Cell Type iPSC Primary Tissue PBMC Reprogramming Method Episomal Plasmid Disease Non-ALS MND.
HighQC™ Human IPSC From PBMC-Non-ALS MND is a disease-specific human induced pluripotent stem cell (iPSC) line derived from peripheral blood mononuclear cells (PBMCs) of a donor diagnosed with a non-amyotrophic lateral sclerosis motor neuron disease (Non-ALS MND). The reprogramming was performed using non-integrating episomal plasmid method. The resulting non-ALS MND iPSCs exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They retain pluripotency for non-ALS MND mechanism exploration. These cells retain the fundamental capacity for trilineage differentiation into cell types of all three germ layers (ectoderm, mesoderm, and endoderm). Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC From PBMC-Non-ALS MND, HighQC™ hiPSC MND, hiPSC-NonALS-MND, HighQC™ Human Induced Pluripotent Stem Cells From Peripheral Blood Mononuclear Cells-Motor Neuron Disease |
| Species | Human |
| Cat.No | ABC-SC2090 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | PBMC |
| Disease | Amyotrophic Lateral Sclerosis |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human IPSC From PBMC-Non-ALS MND provides a patient-specific model for studying heterogeneous motor neuron disorders. Its pluripotent capacity enables directed differentiation into disease-relevant cell types such as motor neurons and glial cells, facilitating investigations into specific neurodegenerative mechanisms, axonopathy, and selective neuronal vulnerability. This system is valuable for modeling diverse MND pathologies, conducting pathway analyses, and performing targeted compound screening.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).